PRME
Price
$3.57
Change
-$0.12 (-3.25%)
Updated
Dec 24 closing price
Capitalization
644.42M
63 days until earnings call
Intraday BUY SELL Signals
YECO
Price
$0.08
Change
-$0.01 (-11.11%)
Updated
Dec 11 closing price
Capitalization
826.21K
Intraday BUY SELL Signals
Interact to see
Advertisement

PRME vs YECO

Header iconPRME vs YECO Comparison
Open Charts PRME vs YECOBanner chart's image
Prime Medicine
Price$3.57
Change-$0.12 (-3.25%)
Volume$2.29M
Capitalization644.42M
Yulong Eco-Materials
Price$0.08
Change-$0.01 (-11.11%)
Volume$3.5K
Capitalization826.21K
PRME vs YECO Comparison Chart in %
PRME
Daily Signal:
Gain/Loss:
YECO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PRME vs. YECO commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a StrongBuy and YECO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (PRME: $3.57 vs. YECO: $0.08)
Brand notoriety: PRME and YECO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 58% vs. YECO: 53%
Market capitalization -- PRME: $644.42M vs. YECO: $826.21K
PRME [@Biotechnology] is valued at $644.42M. YECO’s [@Biotechnology] market capitalization is $826.21K. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileYECO’s FA Score has 0 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • YECO’s FA Score: 0 green, 5 red.
According to our system of comparison, PRME is a better buy in the long-term than YECO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 3 TA indicator(s) are bullish while YECO’s TA Score has 2 bullish TA indicator(s).

  • PRME’s TA Score: 3 bullish, 4 bearish.
  • YECO’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, both PRME and YECO are a bad buy in the short-term.

Price Growth

PRME (@Biotechnology) experienced а -4.55% price change this week, while YECO (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

PRME is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($644M) has a higher market cap than YECO($826K). PRME YTD gains are higher at: 22.260 vs. YECO (-15.393).
PRMEYECOPRME / YECO
Capitalization644M826K77,966%
EBITDA-196.8MN/A-
Gain YTD22.260-15.393-145%
P/E RatioN/A0.01-
Revenue5.98MN/A-
Total Cash213MN/A-
Total Debt118MN/A-
FUNDAMENTALS RATINGS
PRME vs YECO: Fundamental Ratings
PRME
YECO
OUTLOOK RATING
1..100
7994
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
5584
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3146

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRME's Valuation (41) in the null industry is in the same range as YECO (54) in the Construction Materials industry. This means that PRME’s stock grew similarly to YECO’s over the last 12 months.

PRME's Profit vs Risk Rating (100) in the null industry is in the same range as YECO (100) in the Construction Materials industry. This means that PRME’s stock grew similarly to YECO’s over the last 12 months.

PRME's SMR Rating (99) in the null industry is in the same range as YECO (100) in the Construction Materials industry. This means that PRME’s stock grew similarly to YECO’s over the last 12 months.

PRME's Price Growth Rating (55) in the null industry is in the same range as YECO (84) in the Construction Materials industry. This means that PRME’s stock grew similarly to YECO’s over the last 12 months.

PRME's P/E Growth Rating (100) in the null industry is in the same range as YECO (100) in the Construction Materials industry. This means that PRME’s stock grew similarly to YECO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PRMEYECO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
PRME
Daily Signal:
Gain/Loss:
YECO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FHEAX16.520.12
+0.73%
Fidelity Advisor Real Estate A
SWDSX18.100.08
+0.44%
Schwab Dividend Equity
LAFVX20.590.07
+0.34%
Lord Abbett Affiliated R6
AEDMX15.140.04
+0.26%
American Century Emerging Markets R6
BALSX9.66N/A
N/A
BlackRock U.S. Insights Lon/Shr Eq Inv A

YECO and

Correlation & Price change

A.I.dvisor tells us that YECO and TNXP have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YECO and TNXP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YECO
1D Price
Change %
YECO100%
N/A
TNXP - YECO
26%
Poorly correlated
+0.03%
BIESF - YECO
26%
Poorly correlated
N/A
BSFAF - YECO
24%
Poorly correlated
N/A
XBIT - YECO
-0%
Poorly correlated
+0.81%
PRME - YECO
-1%
Poorly correlated
-3.25%
More